FDA OKs implant for enlarged prostate symptoms

September 13, 2013

(AP)—Federal health regulators have approved the first permanent implant to treat men's urinary problems caused by an enlarged prostate.

The Food and Drug Administration says it approved the Urolift system to relieve low or blocked urine flow in men age 50 or older. The implant works by holding back that presses against the urethra, causing difficulty urinating.

More than half of men in their sixties have some due to enlarged prostate, including frequent urination, weak stream and leaking. Current treatment options include drug therapy and surgery to remove part of the prostate. The Urolift is implanted by a doctor using a handheld device that is inserted through the urethra.

Side effects reported in company trials include pain during urination, blood in urine and decreased urine flow.

Explore further: Popular supplement - saw palmetto extract - has no effect on prostate health: study

Related Stories

Recommended for you

Taking aim at rare cancer variants

July 29, 2016

If you walked into a cancer clinic ten years ago as a newly diagnosed patient, you'd likely get "standard of care" treatment based on the location of the cancer in your body and its stage. Make that same visit today and your ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.